483 Goodwin Biotechnology Apr 2019

483 Goodwin Biotechnology Apr 2019

Susan Hadman FDA, Jose Velez FDA$119.00 - Available Now

FDA investigators audited the Goodwin Biotechnology - Plantation, FL, United States facility and issued inspectional observations (via FDA 483) on 10 Apr 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 10 Apr 2019
  • Location: Plantation, United States
  • FEI: 3001861303
Add To Cart